Lenka Sadilkova
Director, Non-Clinical Projects Operations Eli Lilly & Co.
Seminars
Wednesday 2nd December 2026
Insights Exchange – What Drives Confidence in Translational Decision Making?
8:50 am
- Which datasets provide the greatest confidence when progressing a candidate?
- How can teams determine whether a preclinical signal is meaningful enough to justify investment?
- What are the biggest barriers to translating promising biology into clinical success?
- Audience Q&A
Wednesday 2nd December 2026
Insights Exchange – How Can We Better Predict Clinical Success Before the Clinic?
11:40 am
- Which preclinical endpoints, biomarkers, and model characteristics are most consistently associated with successful clinical outcomes?
- How can organisations use clinical observations, imaging, and translational data to improve confidence in model-derived decisions and reduce late-stage risk?
- What are the most common reasons promising preclinical programmes fail in patients, and how can model strategies be refined to improve predictability?
- Audience Q&As
Wednesday 2nd December 2026
Chair’s Opening Remarks
8:05 am
Wednesday 2nd December 2026
Chair’s Closing Remarks
5:10 pm
